Who is Involved


PreDiCT-TB brings together some of the best European scientists in the field of tuberculosis but also those with new ideas from other fields. As importantly, the consortium already comprises almost 100 people with diverse skills. Laboratory scientists, pharmacometricians, systems biologists, engineers, clinical trialists, computer scientists and project managers will work together to make this fresh approach a reality. From another standpoint, by fusing academic innovation with industry expertise and focus on drug development, we aim to find novel solutions to the problem of developing combination TB treatment.

Consortium Partners

PreDiCT-TB brings together twenty-one leading European research partners in tuberculosis from both Industry and Academia

View More

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

The communication contained within this site reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained therein.